7:30 am

Registration/Continental Breakfast/Networking

 

8:00

Welcoming Remarks
David Resnick, Partner, Nixon Peabody LLP

 

8:15

Keynote Address: Felix W. Frueh, PhD
Associate Director for Genomics
Office of Clinical Pharmacology and Biopharmaceutics, CDER/FDA

 

8:50

The Current State of Personalized Medicine
Moderator:
Edward Abrahams, Executive Director, Personalized Medicine Coalition

Panelists:
J. Russell Teagarden MPH, RPH, Vice President, Clinical Practice Medco Health Solutions, Inc.
Linda McAllister MD, PhD, Director, Technology Management U.S. Chief Technology Office Roche Diagnostics
Keith Batchelder MD, Founder and CEO Genomic Healthcare Strategies

 

9:40

Break

 

10:10

What Problems Have To Be Solved?
Moderator:
Fintan Steele, Senior Vice President, MOlecular Medicine Feinstein Keane Healthcare

Panelists:
Lita Nelsen, Director MIT Technology Licensing Office
David Resnick, Partner Nixon Peabody
David Lester, PhD, SVP, Strategy and Corporate Development Gene Express, Inc.

 

11:00

Where Is the Money Going?
Moderator:
Peter Miller, COO Genomic Healthcare Strategies

Panelists:
Linda Grais, MD, Partner InterWest Partners
Bruce Booth, Principal, Atlas Venture
Jim Saalfield, Managing General Partner, Still River Funds

 

12:00

LUNCH

Discussion with Patrice M. Milos, PhD, Vice President & Chief Scientific Officer Helicos BioSciences Corporation

 

1:10

Diagnostics Company/Case Study
Moderator:
Mark Trusheim, President Co-BIO Consulting

Panelists:
Marsha A. Moses, Ph.D. (Co-Founder) Professor, Harvard Medical School and Children's Hospital Boston, Predictive Biosciences
Michael Greeley, General Partner, DG Ventures
Eugene Chiu Co-Founder and Vice President of Business Development Predictive Bioscience

 

2:10

What the Future Holds
Moderator:
Keith Batchelder, MD, Founder & CEO Genomic Healthcare Strategies

Panelists:
Mari Baker, President and CEO Navigenics
Jason Bobe, Harvard George Church Personal Genome Project
Peter Miller, COO Genomic Healthcare Strategies

 

3:00

Closing Remarks
Keith F. Batchelder MD; CEO, Genomic Healthcare Strategies

 

3:15

Refreshments and Networking